Sulbutiamine
Best-in-class: Sulbutiamine
A fat-soluble, brain-penetrant form of vitamin B1 used for mental energy, motivation and focus — with a mild dopaminergic lift.
Sulbutiamine quick facts
| Suggested dose | 200–600 mg, earlier in the day; cycle to avoid tolerance. |
| How often | Daily, cycled |
| Who it's for | Mental energy, motivation and focus. |
Developed and trialed specifically for asthenia — fatigue with a mental rather than muscular character, which is a useful distinction most fatigue supplements ignore. Tolerance develops with daily use, so intermittent dosing preserves the effect. Some people find it mood-elevating enough to be habit-forming in a behavioral sense. A genuinely under-known compound.
How Sulbutiamine actually works
Two thiamine molecules bound by a disulfide bridge, making it lipophilic enough to cross the blood-brain barrier far more readily than thiamine itself. Centrally it raises thiamine pyrophosphate and appears to increase dopaminergic and cholinergic transmission in the prefrontal cortex — an effect beyond simple vitamin repletion.
Where to get Sulbutiamine
Find Sulbutiamine on iHerb →The evidence for Sulbutiamine
Graded by what exists behind each claim.
✅ Clinically validated
- Studied for reducing fatigue (including chronic fatigue) and improving attention/memory.
- Crosses into the brain far better than regular thiamine.
📊 Correlative data
- No meaningful observational or traditional-use literature — a synthesized or isolated compound whose entire evidence base is trials and mechanism. Worth stating rather than leaving blank: it means there is no population-level signal either supporting or contradicting what the trials show.
🧪 Theoretical / extrapolated benefits
- Mood/motivation effects may be dopaminergic; tolerance can develop, so cycle it.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Sulbutiamine actually does
Sulbutiamine is two thiamine molecules stitched together. The thiazolium ring of each is opened, the resulting thiols are joined into a disulfide bridge, and the hydroxyls are esterified as isobutyrates. The product is a lipophilic, uncharged dimer — which is the entire point, because ordinary thiamine is a permanently charged thiazolium cation that has to be carried across membranes by the saturable transporters ThTR-1 and ThTR-2. A charged vitamin queues for a transporter; a neutral disulfide walks through the membrane Starling-Soares 2020.
Inside the cell the bridge is cut and the vitamin reassembles. Cellular thiol-reducing systems — glutathione and thioredoxin — reduce the disulfide, the ring recloses, and thiamine pyrophosphokinase phosphorylates the result to thiamine diphosphate, the cofactor that pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase and transketolase cannot work without. So the delivery trick is a redox trick, and it puts the molecule downstream of a cell's own reducing capacity.
The rodent finding that shows it is doing more than repleting a vitamin. Injected sulbutiamine raises thiamine triphosphate in rat tissues Bettendorff 1990. Thiamine triphosphate is not a cofactor for any of the classic thiamine enzymes; it is a separate, minor phosphorylated derivative with its own biology. A compound that shifts the distribution of thiamine derivatives rather than simply raising the pool is behaving pharmacologically.
And then the part that is not vitamin biochemistry at all. Chronic sulbutiamine in rats decreased kainate binding sites and increased D1 dopamine receptor density in prefrontal and cingulate cortex Trovero 2000. Those are receptor density changes in glutamatergic and dopaminergic systems. This is the mechanism behind the drive and motivation people report, it has nothing to do with carbohydrate metabolism, and receptor-density adaptation is also precisely how tolerance is built — which makes the cycle-it-or-lose-it advice on the label a prediction of the pharmacology rather than folklore.
Cell, rodent, human — and where it stops
In mice. 300 mg/kg daily for 10 days improved retention measured 24 hours after partial acquisition of a task, accompanied by a 10% increase in hippocampal choline uptake — hence the cholinergic reading of the effect Micheau 1985.
In rats. 12.5 or 25 mg/kg daily for 9 weeks improved object recognition memory and reduced the amnesia produced by dizocilpine in a delayed non-match-to-sample task Bizot 2005; separately, the receptor-density changes above, after chronic dosing Trovero 2000; and the thiamine triphosphate rise, after injection Bettendorff 1990. Note the route on that last one, because it is the one most often quoted as though it were an oral human result.
In people, and there is exactly one proper randomized trial. 326 general-practice patients with chronic post-infectious fatigue were randomized to sulbutiamine 400 mg (n = 106), 600 mg (n = 111) or placebo (n = 109) for 28 days. There was a reduction in fatigue in women at 600 mg at day 7, p < 0.01 — and no persistent effect by day 28 Tiev 1999.
The other human data is open-label. Twenty-six patients with multiple sclerosis took 400 mg daily for two months; Fatigue Impact Scale scores fell from 77 to 60.5 with significant improvement on the physical, cognitive and psychosocial subscales, all p < 0.01 Sevim 2017. No placebo arm, and fatigue scales in an unblinded study move on attention alone.
So here is the obstacle, and it is more interesting than the usual one. The randomized human evidence is not merely thin, it has a shape: present at one week, absent at four Tiev 1999. That is the same shape as the tolerance the receptor data predicts Trovero 2000 and the same shape users describe. The trial did not fail to find an effect; it found one and then watched it go. And every participant had a fatigue syndrome. Nobody has ever tested this compound for mental energy in a healthy adult.
Sulbutiamine — which form, and does it matter
Sulbutiamine, benfotiamine and thiamine are three different drugs, and the comparison has been done properly. In mice, benfotiamine at 100 mg/kg raised thiamine in blood and liver but not in brain; the lipid-soluble thiamine disulfide derivatives, the class sulbutiamine belongs to, are the ones that reach brain Volvert 2008. Benfotiamine is an S-acyl compound, not a disulfide, and that structural difference is the whole reason the two go to different places. If the goal is diabetic neuropathy or peripheral thiamine status, benfotiamine is the correct tool and sulbutiamine is not; if the goal is central, the reverse holds.
Plain thiamine cannot be dose-escalated into the brain. Transport across the blood-brain barrier is carrier-mediated and saturable, so beyond a modest intake extra thiamine hydrochloride raises urinary thiamine rather than brain thiamine Starling-Soares 2020. That is the specific reason this molecule was synthesized, and it is also the reason sulbutiamine is the wrong answer to a genuine deficiency: for repletion, cheap thiamine works and costs almost nothing.
It is a prescription medicine where it was developed. Sulbutiamine is Arcalion, licensed for asthenia in France and elsewhere, and the 400 to 600 mg doses in the literature are drug doses from a drug trial Tiev 1999. A 200 mg capsule bought online is a sub-trial dose of a foreign prescription product.
And it is detectable, which matters for one group of buyers. Screening of roughly 16,000 doping control samples found around 100 containing sulbutiamine above 500 ng/mL, predominantly in-competition Sobolevsky 2010. Whatever else that tells you, it establishes that this compound is taken as a stimulant, is measurable in urine, and shows up on the days people are trying to perform.
What would have to be true, and how you would know it was not
1. Test the day-7 shape, because the trial already told you what to expect. Score one fixed task — a timed digit-symbol substitution or a defined 25-minute work block with a count attached — on day 1, day 7 and day 28 at 400 to 600 mg. Predict a measurable improvement at day 7 and its disappearance by day 28, which is exactly what happened in 326 randomized patients Tiev 1999. If your day-28 score is still elevated, you have found something the only randomized trial did not.
2. The prediction that cuts against the product, and it is a blood test. Before you attribute fatigue to a thiamine derivative, predict that ferritin, TSH and vitamin B12 explain more of it than the capsule does. Those three are ordinary, cheap and are the common correctable causes. A stimulating compound that papers over a low ferritin has bought a few good weeks and cost you the diagnosis, and the mechanism here — D1 receptor up-regulation Trovero 2000 — is exactly the kind that masks rather than corrects.
3. A prediction about who cannot respond. If you are not thiamine-deficient, the thiamine-diphosphate-dependent enzymes are already saturated and there is no cofactor headroom to gain. So predict that any effect you feel in a well-nourished person is the dopaminergic-glutamatergic arm rather than the vitamin arm Trovero 2000 Bettendorff 1990 — which reframes what you are taking and explains why the effect fades.
What will fool you: the stop. Coming off after weeks of daily use produces a flatness that reads as proof the compound was working. On a receptor-density mechanism, that flatness is the adaptation unwinding, and it is the same observation either way.
What nobody has tested yet
Nobody has measured thiamine derivatives in a human brain on sulbutiamine. The thiamine triphosphate result is rats, by injection Bettendorff 1990; the brain-penetration comparison is mice Volvert 2008. In humans, magnetic resonance spectroscopy or even a cerebrospinal fluid thiamine measurement in a small pharmacokinetic study would say whether the central mechanism happens at oral doses. It has not been done.
Nobody has run a placebo-controlled trial past 28 days. The one randomized study stops exactly where the interesting question starts Tiev 1999. A 12-week trial with a randomized withdrawal would separate tolerance from a real plateau, and would test the cycling advice everybody gives and nobody has evidence for.
Nobody has tested it in healthy people. Every human dataset is a fatigue population — post-infectious Tiev 1999, multiple sclerosis Sevim 2017 — and the review literature says as much while calling for better trials Starling-Soares 2020. The people buying it are mostly well.
And nobody has asked whether the D1 up-regulation reverses. Rats got 9 weeks Bizot 2005 and receptor densities were measured on drug Trovero 2000; no study has measured them after withdrawal. That single experiment would tell you whether the reported post-cycle flatness is a real neurochemical rebound or a mood.
Sulbutiamine — its own safety story, not its category's
The documented human harm is not organ toxicity, it is escalation. There is a published case of a patient taking ever-increasing quantities of sulbutiamine — an over-the-counter drug treated as innocent — whose use compromised the treatment of their bipolar disorder, through defaulted appointments and changes of psychiatrist Douzenis 2006. That is a single case, and it is also the only human harm report this compound has, so it is worth reading rather than skipping: the failure mode is behavioral, and it is what a D1-active compound with fast tolerance Trovero 2000 would be expected to produce.
Bipolar disorder is the specific exclusion. A compound that raises dopaminergic tone and is escalated when it stops working is the wrong shape for a condition defined by episodes of elevated mood, and the one case report in the literature is exactly that combination Douzenis 2006.
Tolerance is the dominant practical problem and it has a timeline. The effect in the only randomized trial was gone by four weeks Tiev 1999. Headache, agitation and nausea are the acute complaints. There is no long-term safety dataset: the human trials run 28 days and two months Tiev 1999 Sevim 2017, which is the honest limit on anything anyone can tell you about years of daily use.
Tested athletes should treat this as a finding, not a supplement. It is detectable in urine above 500 ng/mL and was found in around 100 of roughly 16,000 doping samples, mostly in-competition Sobolevsky 2010. Check your sport's list before, not after.
Who should not take it: anyone with bipolar disorder or a history of hypomania; anyone whose fatigue has not been worked up with at least a full blood count, ferritin, TSH and B12; anyone with a history of escalating use of a stimulant; and anyone intending to take it continuously, since the only randomized evidence says that is the one way to guarantee it stops working Tiev 1999.
Sources read for this page
- Bettendorff L, et al. Injection of sulbutiamine induces an increase in thiamine triphosphate in rat tissues. Biochemical Pharmacology 1990 · PMID 2268373
- Trovero F, et al. Evidence for a modulatory effect of sulbutiamine on glutamatergic and dopaminergic cortical transmissions in the rat brain. Neuroscience Letters 2000 · PMID 10996447
- Micheau J, et al. Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation. Pharmacology Biochemistry and Behavior 1985 · PMID 4059305
- Bizot JC, et al. Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005 · PMID 15951087
- Tiev KP, et al. Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo. Revue de Medecine Interne 1999 · PMID 10573727
- Sevim S, et al. Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders 2017 · PMID 28755683
- Douzenis A, et al. Sulbutiamine, an 'innocent' over the counter drug, interferes with therapeutic outcome of bipolar disorder. World Journal of Biological Psychiatry 2006 · PMID 16861144
- Volvert ML, et al. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacology 2008 · PMID 18549472
- Starling-Soares B, et al. Role of the Synthetic B1 Vitamin Sulbutiamine on Health. Journal of Nutrition and Metabolism 2020 · PMID 32399290
- Sobolevsky T, et al. Sulbutiamine in sports. Drug Testing and Analysis 2010 · PMID 21204296
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Drive on the days you have to start something you do not want to start. Its record is in fatigue rather than in cognition, so the endpoint is initiation and stamina across a working day, not test scores.
- How long before it means anything: One to two weeks, then a deliberate break. The break is the measurement: tolerance builds fast enough that a month of uninterrupted daily use will hide the effect from you, and only stopping shows you what you had.
- What will fool you: Blaming tiredness on a thiamine problem you do not have. Persistent fatigue has causes a blood draw finds — iron stores, thyroid function, B12 — and a stimulating B1 derivative that masks one of them has bought you a few good weeks and cost you the diagnosis. Get the fatigue explained before you medicate it.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Sulbutiamine — safety & side effects
- Headache, agitation and nausea. Tolerance develops fast and is the main practical issue — the effect fades within days of continuous use.
- User reports describe mood disturbance and a withdrawal-like flatness after extended daily use. Cycle it.
- Caution in bipolar disorder — reports of hypomania. Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Sulbutiamine in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Sulbutiamine
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Sulbutiamine — frequently asked questions
What is Sulbutiamine?
A fat-soluble, brain-penetrant form of vitamin B1 used for mental energy, motivation and focus — with a mild dopaminergic lift.
What is the suggested dose of Sulbutiamine?
200–600 mg, earlier in the day; cycle to avoid tolerance. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Sulbutiamine dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Sulbutiamine?
Coach Cam sources Sulbutiamine from vetted, top-rated brands on iHerb — use the buy link on this page.
Sulbutiamine inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Sulbutiamine is used for
Sulbutiamine appears under 2 goals in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Sulbutiamine is the dopaminergic arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.